Spravato Side Effects, Success Rate, and How Quickly It Works

Get Started
Spravato Side Effects, Success Rate, and How Quickly It Works

If you have been under treatment for depression and nothing seems to work, you go on google and Spravato comes up. So, now, you probably have three questions that you want to be answered. What does it actually feel like, does it work, and how long before you know either way. If you’ve already tried a couple of antidepressants and hit the same wall each time, you’ve probably learned to be skeptical of anything that sounds too promising. And that skepticism is fair.

This blog walks through what the side effect data actually shows, what success looks like in real trial results, and the honest timeline for feeling a difference. Some of this will sound encouraging, some of it will sound more cautious, but the aim is to give you a clear picture.

What Is Spravato and How Fast Does It Work?

FDA-Approved for Treatment-Resistant Depression

Spravato is the brand name for esketamine, a nasal spray approved by the FDA for depression that hasn’t responded to standard antidepressants. It works through the brain’s glutamate system instead of serotonin, which is part of why it can act faster than a typical SSRI.

How Quickly Does Spravato Work? A First Look

Some patients notice a shift in mood within hours of a first dose. Others need the full four week induction period before a real difference shows up. Both are normal, and neither is a sign the treatment is failing.

How Quickly Does Spravato Work? A Closer Look at the Timeline

Relief Within 24 Hours: What the Research Shows

For patients being treated for major depressive disorder with acute suicidal ideation, trial data has shown symptom improvement within 24 hours of a first dose for many patients. That’s part of why Spravato sometimes gets used in urgent situations where waiting weeks isn’t an option.

The Induction Phase vs. Longer-Term Results

For treatment-resistant depression specifically, the timeline looks different. Induction runs twice weekly for the first month, and the effects are thought to build across sessions rather than land all at once. Most providers wait until the end of that four week period before judging whether it’s working.

Why Results Can Vary by Patient

How long someone’s been depressed, how many treatments they’ve already tried, and their overall health all shape the timeline. Nobody can promise you a specific number of days.

See if you qualify for fast-acting Spravato treatment → /survey

Spravato Success Rate: What the Data Shows

Clinical Response and Remission Rates

A 2023 trial compared Spravato plus an oral antidepressant against quetiapine, an antipsychotic sometimes added to antidepressants for treatment-resistant depression. At eight weeks, just over a quarter of the Spravato group reached remission, compared to under a fifth of the quetiapine group. By 32 weeks, nearly half the Spravato group was in remission versus under a third for quetiapine. That matters because it compares Spravato to an active treatment, not a placebo.

Real Patient Outcomes at Marpa Minds

Internal reporting from Marpa Minds’ own patient base suggests a majority notice a reduction in depressive symptoms within 24 hours of that first session, though individual timelines vary and this isn’t something any provider can promise in advance.

Factors That Influence Success Rate

Prior treatment history, severity of depression, and consistency with the full induction schedule all play a role. Skipping sessions or stopping early tends to blunt results.

Spravato Side Effects: What’s Normal

Common Short-Term Side Effects (Dissociation, Dizziness, Nausea)

The most frequently reported effects are dissociation, a floaty or disconnected feeling, along with dizziness, nausea, sedation, and a temporary rise in blood pressure. Altered taste and mild vertigo come up often too.

How Long Side Effects Typically Last

These effects tend to show up within the first 30 to 40 minutes after dosing and settle down well within the required two hour observation window.

Why the Two-Hour Monitoring Period Matters

That window isn’t a clinic preference. It’s a federal safety requirement built into how Spravato was approved, and it exists specifically to catch side effects early while they’re still manageable.

Rare but Serious Spravato Side Effects to Watch For


Blood Pressure Changes

Blood pressure can stay elevated for up to four hours after a dose. Providers check it before dosing, again around the 40 minute mark, and periodically after that until it returns to a safe range.

Sedation and Cognitive Effects

Spravato carries a boxed warning, the FDA’s most serious warning category, for sedation, dissociation, and slowed breathing. This is exactly why direct observation is required for every dose, not just the first one.

When to Contact Your Care Team

In FDA trial data, the most common reason patients stopped Spravato was anxiety, and even that affected just over 1 percent of patients. Severe enough to end treatment is rare. Mild and temporary is the norm.

Have more questions about side effects? Browse our FAQ →

Balancing Speed of Relief With Safety

Why In-Clinic Administration Reduces Risk

Because Spravato has to be given under direct observation, side effects get caught while a trained provider is right there, not hours later at home.

How Marpa Minds Monitors Every Session

Every session includes vital sign checks before, during, and after dosing, with a provider present the entire time and for the full recovery period.

Spravato Side Effects and Success Rate vs. Other Treatments

Comparing to Oral Antidepressants

Standard antidepressants typically take four to eight weeks to show an effect, with a much lower chance of rapid relief. Spravato’s speed is the main practical trade-off against its more involved monitoring requirements.

Comparing to IV Ketamine and TMS

IV ketamine works through a similar glutamate mechanism but lacks Spravato’s FDA approval for depression. TMS avoids sedation and dissociation entirely but requires daily visits over several weeks instead of twice weekly sessions. This comparison breaks down the differences in more depth.

Why Patients Choose Marpa Minds for Spravato Treatment

Supportive, Spa-Like Clinical Environment

A large part of treatment involves sitting with a provider for an extended period. Marpa Minds built its clinics to feel like a quiet, private space rather than a standard medical waiting room.

Licensed Clinicians Guiding Every Session

A trained provider oversees every dose, from administration through discharge, watching for exactly the signals that matter for both safety and results.

Insurance-Covered, FDA-Approved Care

Marpa Minds verifies insurance benefits and manages prior authorization directly, and most major plans along with Medicare Part B cover Spravato once approved.

Frequently Asked Questions

How quickly does Spravato start working? 

Some patients notice change within 24 hours, particularly for acute suicidal ideation. For treatment-resistant depression, most providers assess results at the end of the four week induction phase.

What is the success rate of Spravato for depression?

In a 2023 trial against quetiapine, about 27 percent of the Spravato group reached remission by eight weeks, rising to nearly 50 percent by 32 weeks. Individual results vary.

What are the most common Spravato side effects? 

Dissociation, dizziness, nausea, sedation, and a temporary rise in blood pressure are the most frequently reported effects.

How long do Spravato side effects last? 

Most side effects peak within 30 to 40 minutes after dosing and resolve within the required two hour monitoring window. Blood pressure can occasionally stay elevated for up to four hours.

Are Spravato’s side effects dangerous? 

Serious side effects are rare. In FDA trial data, the most common reason patients discontinued treatment was anxiety, affecting just over 1 percent of patients.

How is Spravato’s success rate measured? 

Success is typically measured through remission and response rates in clinical trials, tracked using standardized depression rating scales over the full induction and maintenance period, not after a single dose.

This article is for informational purposes and isn’t a substitute for medical advice. Talk with a licensed clinician about whether Spravato is appropriate for your specific situation.

Ready to experience fast, effective relief? Get Started Now →

About Author